Major Improvements in Robustness and Efficiency during the Screening of Novel Enzyme Effectors by the 3-Point Kinetics Assay.
Artifacts
Ataxin-3
/ chemistry
Coumarins
/ chemistry
Deubiquitinating Enzymes
/ chemistry
Drug Discovery
/ methods
Drug Repositioning
Enzyme Activators
/ chemistry
Enzyme Inhibitors
/ chemistry
Enzymes
/ chemistry
High-Throughput Screening Assays
Humans
Kinetics
Repressor Proteins
/ chemistry
Sensitivity and Specificity
Ubiquitin
/ chemistry
Machado–Joseph disease
ataxin-3
drug repurposing
enzyme kinetics
high-throughput screening
Journal
SLAS discovery : advancing life sciences R & D
ISSN: 2472-5560
Titre abrégé: SLAS Discov
Pays: United States
ID NLM: 101697563
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
29
9
2020
medline:
1
3
2022
entrez:
28
9
2020
Statut:
ppublish
Résumé
The throughput level currently reached by automatic liquid handling and assay monitoring techniques is expected to facilitate the discovery of new modulators of enzyme activity. Judicious and dependable ways to interpret vast amounts of information are, however, required to effectively answer this challenge. Here, the 3-point method of kinetic analysis is proposed as a means to significantly increase the hit success rates and decrease the number of falsely identified compounds (false positives). In this post-Michaelis-Menten approach, each screened reaction is probed in three different occasions, none of which necessarily coincide with the initial period of constant velocity. Enzymology principles rather than subjective criteria are applied to identify unwanted outliers such as assay artifacts, and then to accurately distinguish true enzyme modulation effects from false positives. The exclusion and selection criteria are defined based on the 3-point reaction coordinates, whose relative positions along the time-courses may change from well to well or from plate to plate, if necessary. The robustness and efficiency of the new method is illustrated during a small drug repurposing screening of potential modulators of the deubiquinating activity of ataxin-3, a protein implicated in Machado-Joseph disease. Apparently, intractable Z factors are drastically enhanced after (1) eliminating spurious results, (2) improving the normalization method, and (3) increasing the assay resilience to systematic and random variability. Numerical simulations further demonstrate that the 3-point analysis is highly sensitive to specific, catalytic, and slow-onset modulation effects that are particularly difficult to detect by typical endpoint assays.
Identifiants
pubmed: 32981414
doi: 10.1177/2472555220958386
pii: S2472-5552(22)06686-2
doi:
Substances chimiques
Coumarins
0
Enzyme Activators
0
Enzyme Inhibitors
0
Enzymes
0
Repressor Proteins
0
Ubiquitin
0
ATXN3 protein, human
EC 3.4.19.12
Ataxin-3
EC 3.4.19.12
Deubiquitinating Enzymes
EC 3.4.19.12
7-amino-4-methylcoumarin
OCY3JCT44X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM